KNOWLEDGE AND AWARENESS AMONG DENTAL STUDENTS REGARDING SCREENING TECHNIQUES FOR DOWN SYNDROME DURING GESTATION
DOI:
https://doi.org/10.61841/sk5qah95Keywords:
Down syndrome, ultrasounds, maternal serum tests, hCG, soft markers, nuchal translucencyAbstract
Down syndrome is one of the most important causes of mental retardation in the world population. The purpose of prenatal screening is to identify those women at increased risk for an affected pregnancy and to maximize the options available to these women. Second trimester serum screening for chromosomal aneuploidies involves combining the maternal age-specific risk for an affected pregnancy with the risks associated with the concentrations of maternal serum alpha-fetoprotein (MSAFP), unconjugated estriol (uE3), and human chorionic gonadotropin (hCG) (triple testing). A fourth analyte, inhibin-A (INH-A), is increasingly being utilized (quadruple testing). These techniques, when employed with ultrasound soft marker scanning, give a true positive rate of 88% and significantly reduce the false positives. A questionnaire-based study was conducted among dental students of third and fourth year students and interns at a private dental college in Chennai, Tamilnadu, India, to assess their knowledge and awareness of prenatal screening techniques for Down syndrome. A multiple-choice questionnaire was presented to 106 subjects, and their responses were noted and tabulated, and statistical analysis was performed using SPSS by IBM by performing a chi-square test. Among 106 subjects, 40 (37.7%) were interns, 33 (31.13%) were third-year students, and the remaining 33 were fourth-year students. Interns and third-year students had more knowledge and awareness regarding the prenatal screening techniques employed to diagnose Down syndrome in fetuses with a significant p-value < 0.05.
Downloads
References
1. Ajay R, Suma K, Ali SA, et al. (2017) Effect of Surface Modifications on the Retention of Cement-retained
Implant Crowns under Fatigue Loads: An In vitro Study. Journal of pharmacy &bioallied sciences 9(Suppl
1). ncbi.nlm.nih.gov: S154–S160.
2. Arias F, Bhide AG, Arulkumaran S, et al. (2019) Arias’ Practical Guide to High-Risk Pregnancy and
Delivery: A South Asian Perspective. Elsevier Health Sciences.
3. Ashok V and Suvitha S (2016) Awareness of all ceramic restoration in rural population. Research Journal of
Pharmacy and Technology 9(10). A & V Publications: 1691–1693.
4. Baird PA and Sadovnick AD (1987) Life expectancy in Down syndrome. The Journal of pediatrics 110(6):
849–854.
5. Baird PA and Sadovnick AD (1989) Life tables for Down syndrome. Human genetics 82(3): 291–292.
6. Basha FYS, Ganapathy D and Venugopalan S (2018) Oral Hygiene Status among Pregnant Women.
Research Journal of Pharmacy and Technology 11(7). A & V Publications: 3099–3102.
7. Benn PA (2002a) Advances in prenatal screening for Down syndrome: I. general principles and second
trimester testing. Clinicachimica acta; international journal of clinical chemistry 323(1-2): 1–16.
8. Benn PA (2002b) Advances in prenatal screening for Down syndrome: II first trimester testing, integrated
testing, and future directions. Clinicachimica acta; international journal of clinical chemistry 324(1-2): 1–
11.
9. Bogart MH, Pandian MR and Jones OW (1987) Abnormal maternal serum chorionic gonadotropin levels in
pregnancies with fetal chromosome abnormalities. Prenatal diagnosis 7(9): 623–630.
10. Canick JA, Knight GJ, Palomaki GE, et al. (1988) Low second trimester maternal serum unconjugated
oestriol in pregnancies with Down’s syndrome. British journal of obstetrics and gynaecology 95(4): 330–
333.
11. Chard T (1991) Biochemistry and endocrinology of the Down’s syndrome pregnancy. Annals of the New
York Academy of Sciences 626: 580–596.
12. Cuckle HS, Wald NJ and Lindenbaum RH (1984) Maternal serum alpha-fetoprotein measurement: a
screening test for Down syndrome. The Lancet 1(8383): 926–929.
13. Drugan A, Johnson MP and Evans MI (2000) Ultrasound screening for fetal chromosome anomalies.
American journal of medical genetics 90(2): 98–107.
14. Duraisamy R, Krishnan CS, Ramasubramanian H, et al. (2019) Compatibility of Nonoriginal Abutments
With Implants: Evaluation of Microgap at the Implant–Abutment Interface, With Original and Nonoriginal
Abutments. Implant dentistry 28(3). journals.lww.com: 289.
15. Egan JF, Benn P, Borgida AF, et al. (2000) Efficacy of screening for fetal Down syndrome in the United
States from 1974 to 1997. Obstetrics and gynecology 96(6): 979–985.
16. Epstein CJ (1989) Down Syndrome. In: Hobson JA (ed.) Abnormal States of Brain and Mind. Boston, MA:
Birkhäuser Boston, pp. 43–44.
17. Fonseca EB da, Cruz J, Sá R de A, et al. (2014) Rastreamento de aneuploidias no primeirotrimestre de
gestação: evolução da idadematerna à avaliação do DNA fetal livre no sanguematerno. Femina: revista da
FederacaoBrasileira das Sociedades de Ginecologia e Obstetricia: 87–93.
18. Fuhrmann W, Wendt P and Weitzel HK (1984) Maternal serum-AFP as screening test for Down syndrome.
The Lancet 2(8399): 413.
19. Ganapathy D, Sathyamoorthy A, Ranganathan H, et al. (2016) Effect of Resin Bonded Luting Agents
Influencing Marginal Discrepancy in All Ceramic Complete Veneer Crowns. Journal of clinical and
diagnostic research: JCDR 10(12). ncbi.nlm.nih.gov: ZC67–ZC70.
20. Jain AR, Nallaswamy D, Ariga P, et al. (2018) Determination of correlation of width of maxillary anterior
teeth using extraoral and intraoral factors in Indian population: A systematic review. World J Dent 9.
researchgate.net: 68–75.
21. Jyothi S, Robin PK, Ganapathy D, et al. (2017) Periodontal health status of three different groups wearing
temporary partial denture. Research Journal of Pharmacy and Technology 10(12). A & V Publications:
4339–4342.
22. Kagan KO, Wright D, Baker A, et al. (2008) Screening for trisomy 21 by maternal age, fetal nuchal
translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma proteinA. Ultrasound in Obstetrics and Gynecology. DOI: 10.1002/uog.5331.
23. Kannan A and Others (2017) Effect of Coated Surfaces influencing Screw Loosening in Implants: A
Systematic Review and Meta-analysis. WORLD 8(6). pdfs.semanticscholar.org: 496–502.
24. Kannan A and Venugopalan S (2018) A systematic review on the effect of use of impregnated retraction
cords on gingiva. Research Journal of Pharmacy and Technology 11(5). A & V Publications: 2121–2126.
25. Li SW, Barrett AN, Gole L, et al. (2015) The assessment of combined first trimester screening in women of
advanced maternal age in an Asian cohort. Singapore medical journal 56(1): 47–52.
26. Macri JN, Kasturi RV, Krantz DA, et al. (1990) Maternal serum Down syndrome screening: unconjugated
estriol is not useful. American journal of obstetrics and gynecology 162(3): 672–673.
27. Manohar J (2016) The Assessment of Nasal Bone during Gestation to Screen for Down Syndrome-A
Review. Research journal of pharmaceutical, biological and chemical sciences 8(7). Journal of
Pharmaceutical Sciences and Research: 607.
28. Merkatz IR, Nitowsky HM, Macri JN, et al. (1984) An association between low maternal serum α-
fetoprotein and fetal chromosomal abnormalities. American journal of obstetrics and gynecology 148(7):
886–894.
29. Mikkelsen M, Poulsen H and Nielsen KG (1990) Incidence, survival, and mortality in Down syndrome in
Denmark. American journal of medical genetics. Supplement 7: 75–78.
30. Nicolaides KH, Spencer K, Avgidou K, et al. (2005) Multicenter study of first-trimester screening for
trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated
two-stage first-trimester screening. Ultrasound in Obstetrics and Gynecology. DOI: 10.1002/uog.1860.
31. Niederstrasser SL, Hammer K, Möllers M, et al. (2017) Fetal loss following invasive prenatal testing: a
comparison of transabdominal chorionic villus sampling, transcervical chorionic villus sampling and
amniocentesis. Journal of Perinatal Medicine. DOI: 10.1515/jpm-2015-0434.
32. Nyberg DA, Resta RG, Luthy DA, et al. (1993) Humerus and femur length shortening in the detection of
Down’s syndrome. American Journal of Obstetrics and Gynecology. DOI: 10.1016/0002-9378(93)90487-4.
33. of Obstetricians AC, Gynecologists and Others (n.d.) ’Committee on Practice Bulletins—Obstetrics;
Committee on Genetics; Society for Maternal--Fetal Medicine. Practice bulletin (162): 976–978.
34. Palomaki GE and Haddow JE (1987) Maternal serum alpha-fetoprotein, age, and Down syndrome risk.
American journal of obstetrics and gynecology 156(2): 460–463.
35. Pan M, Han J, Yang X, et al. (2015) A 1st-trimester combined screening test in pregnant women of
advanced maternal age in a Chinese population. Journal of obstetrics and gynaecology: the journal of the
Institute of Obstetrics and Gynaecology 35(2): 121–124.
36. Park SY, Jang IA, Lee MA, et al. (2016) Screening for chromosomal abnormalities using combined test in
the first trimester of pregnancy. Obstetrics & Gynecology Science. DOI: 10.5468/ogs.2016.59.5.357.
37. Pergament E (2001) Antenatal and neonatal screening.: Edited by Nicholas Wald, Ian Leck. (Pp 591;
pound75.00) Oxford: Oxford University Press, 2000. ISBN 0 19 262826 7. Journal of Medical Screening.
DOI: 10.1136/jms.8.1.55.
38. Ranganathan H, Ganapathy DM and Jain AR (2017) Cervical and Incisal Marginal Discrepancy in Ceramic
Laminate Veneering Materials: A SEM Analysis. Contemporary clinical dentistry 8(2). ncbi.nlm.nih.gov:
272–278.
39. Rowley PT (1984) Genetic screening: marvel or menace? Science 225(4658): 138–144.
40. Selvan SR and Ganapathy D (2016) Efficacy of fifth generation cephalosporins against methicillin-resistant
Staphylococcus aureus-A review. Research Journal of Pharmacy and Technology 9(10). A & V
Publications: 1815–1818.
41. Smith-Bindman R, Hosmer W, Feldstein VA, et al. (2001) Second-trimester ultrasound to detect fetuses
with Down syndrome: a meta-analysis. JAMA: the journal of the American Medical Association 285(8):
1044–1055.
42. Spencer K, Souter V, Tul N, et al. (1999) A screening program for trisomy 21 at 10--14 weeks using fetal
nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy-associated
plasma protein-A. Ultrasound in obstetrics & gynecology: the official journal of the International Society of
Ultrasound in Obstetrics and Gynecology 13(4). Wiley Online Library: 231–237.
43. Spencer K, Spencer CE, Power M, et al. (2000) One stop clinic for assessment of risk for fetal anomalies: a
report of the first year of prospective screening for chromosomal anomalies in the first trimester. BJOG: an
international journal of obstetrics and gynaecology 107(10): 1271–1275.
44. Spencer K, Spencer CE, Power M, et al. (2003) Screening for chromosomal abnormalities in the first
trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years
prospective experience. BJOG: An International Journal of Obstetrics and Gynaecology. DOI:
10.1046/j.1471-0528.2003.02246.x.
45. Subasree S, Murthykumar K and Others (2016) Effect of Aloe Vera in Oral Health-A Review. Research
Journal of Pharmacy and Technology 9(5). A & V Publications: 609–612.
46. Turpin R, Lejeune J and Gautier M (1959) Les chromosomes humainesen culture de tissues. Compt. rend.
Acad.
47. Van Lith JMM, Pratt JJ, Beekhuis JR, et al. (1992) Second-trimester maternal serum immunoreactive
inhibin as a marker for fetal Down’s syndrome. Prenatal Diagnosis. DOI: 10.1002/pd.1970121005.
48. Venugopalan S, Ariga P, Aggarwal P, et al. (2014) Case Report: Magnetically retained silicone facial
prosthesis. Nigerian journal of clinical practice 17(2). ajol.info: 260–264.
49. Verp MS, Bombard AT, Simpson JL, et al. (1988) Parental decision following prenatal diagnosis of fetal
chromosome abnormality. American journal of medical genetics 29(3): 613–622.
50. Vijayalakshmi B and Ganapathy D (2016) Medical management of cellulitis. Research Journal of Pharmacy
and Technology 9(11). A & V Publications: 2067–2070.
51. Wald NJ (1994) Guidance on Terminology. Journal of Medical Screening. DOI:
10.1177/096914139400100118.
52. Wald NJ and Hackshaw AK (1997) Combining ultrasound and biochemistry in first-trimester screening for
Down’s syndrome. Prenatal Diagnosis: Published in Affiliation with the International Society for Prenatal
Diagnosis 17(9). Wiley Online Library: 821–829.
53. Wald NJ, Cuckle HS, Densem JW, et al. (1988) Maternal serum unconjugated oestriol as an antenatal screening test for Down’s syndrome. British journal of obstetrics and gynaecology 95(4): 334–341.
54. Wald NJ, Rodeck C, Hackshaw AK, et al. (2005) SURUSS in perspective. Seminars in perinatology 29(4):225–235.
55. (n.d.). DOI: 3.0.co;2-u">10.1002/(sici)1097-0223(199904)19:4<360: aid-pd556>3.0.co;2-u.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
